Interpreting the RAPIDO trial: factors to consider - Authors' reply

Lancet Oncol. 2021 Mar;22(3):e90-e91. doi: 10.1016/S1470-2045(21)00087-5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Chemoradiotherapy*
  • Chemotherapy, Adjuvant
  • Humans
  • Rectal Neoplasms*
  • Rectum